Home > Boards > US Listed > Telecommunications Hardware > ADC Telecommunications (ADCT)

Good morning Linda, Did you see that ADCT

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
OldAIMGuy Member Profile
Member Level 
Followed By 114
Posts 14,294
Boards Moderated 6
Alias Born 01/29/02
160x600 placeholder
Overland ADCT BioPharma gibt erste Verabreichung an Patienten in China von ZYNLONTA® im Rahmen klinischer Phase-II-Zulassungsstudie zu diffus großzelligem B-Zell-Lymphom bekannt Business Wire - 9/29/2021 5:18:00 PM
Overland ADCT BioPharma annonce la première administration à un patient de ZYNLONTA® dans le cadre d'un essai clinique pivot de Phase 2 conduit en Chine pour le traitement du lymphome diffus à grandes cellules B Business Wire - 9/29/2021 5:16:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/29/2021 7:23:25 AM
Overland ADCT BioPharma Announces First Patient Dosed in China with ZYNLONTA® in Pivotal Phase 2 Clinical Trial for Diffuse Large B-cell Lymphoma Business Wire - 9/29/2021 7:15:00 AM
ADC Therapeutics verabreicht in klinischer Phase-1-Studie zu ADCT-901 bei fortgeschrittenen soliden Tumoren die erste Dosis an einen Patienten Business Wire - 9/27/2021 12:46:00 PM
ADC Therapeutics dose un premier patient dans le cadre d'un essai clinique de Phase 1 avec ADCT-901 pour traiter les tumeurs solides avancées Business Wire - 9/27/2021 9:35:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/27/2021 7:18:44 AM
ADC Therapeutics Doses First Patient in Phase 1 Clinical Trial of ADCT-901 in Advanced Solid Tumors Business Wire - 9/27/2021 7:15:00 AM
ADC Therapeutics nimmt an der Cantor Virtual Global Healthcare Conference 2021 teil Business Wire - 9/23/2021 4:39:00 PM
ADC Therapeutics participera à l’édition 2021 de la Cantor Virtual Global Healthcare Conference Business Wire - 9/23/2021 8:44:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/23/2021 7:23:29 AM
ADC Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference Business Wire - 9/23/2021 7:15:00 AM
ADC Therapeutics erhält Orphan-Drug-Status in Europa für ZYNLONTA® Business Wire - 9/13/2021 9:36:00 PM
ADC Therapeutics a reçu la désignation de médicament orphelin en Europe pour ZYNLONTA® Business Wire - 9/13/2021 8:36:00 AM
ADC Therapeutics Receives Orphan Drug Designation in Europe for ZYNLONTA® Business Wire - 9/13/2021 7:15:00 AM
ADC Therapeutics participera à la 19e conférence annuelle mondiale sur les soins de santé de Morgan Stanley Business Wire - 9/9/2021 1:55:00 PM
ADC Therapeutics nimmt an der 19. jährlichen globalen Gesundheitskonferenz von Morgan Stanley teil Business Wire - 9/9/2021 8:47:00 AM
ADC Therapeutics to Participate in Morgan Stanley’s 19th Annual Global Healthcare Conference Business Wire - 9/9/2021 7:15:00 AM
ADC Therapeutics gibt Wechsel in der medizinischen Führungsspitze bekannt Business Wire - 9/3/2021 3:12:00 PM
ADC Therapeutics annonce une transition au niveau de sa direction médicale Business Wire - 9/3/2021 9:38:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 9/3/2021 7:22:53 AM
ADC Therapeutics Announces Medical Leadership Transition Business Wire - 9/3/2021 7:15:00 AM
ADC Therapeutics schließt Finanzierungsvereinbarung mit HealthCare Royalty im Umfang von bis zu 325 Millionen US-Dollar ab Business Wire - 8/26/2021 7:05:00 PM
ADC Therapeutics conclut un accord de financement avec HealthCare Royalty pour un montant pouvant aller jusqu'à 325 millions USD Business Wire - 8/26/2021 3:42:00 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 8/26/2021 8:35:26 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences